Allianz Asset Management GmbH - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 191 filers reported holding REVANCE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q4 2018$1,422,000
-33.0%
70,621
-17.3%
0.00%0.0%
Q3 2018$2,122,000
-2.2%
85,377
+8.0%
0.00%0.0%
Q2 2018$2,170,000
-11.3%
79,066
-0.5%
0.00%0.0%
Q1 2018$2,447,000
+0.4%
79,437
+16.5%
0.00%0.0%
Q4 2017$2,437,000
+53.0%
68,166
+17.9%
0.00%
+100.0%
Q3 2017$1,593,000
+7.2%
57,822
+2.7%
0.00%0.0%
Q2 2017$1,486,000
+41.1%
56,285
+11.2%
0.00%0.0%
Q1 2017$1,053,00050,6130.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Palo Alto Investors LP 4,405,039$118,936,0009.40%
Essex Woodlands Management, Inc. 457,085$12,341,0005.10%
Evolutionary Tree Capital Management, LLC 191,868$5,180,0004.98%
Ghost Tree Capital, LLC 390,000$10,530,0002.96%
Antara Capital LP 4,069,400$109,874,0002.90%
RICE HALL JAMES & ASSOCIATES, LLC 896,754$24,212,0001.40%
Jericho Capital Asset Management L.P. 714,000$19,278,0001.22%
Antara Capital LP 1,600,000$43,200,0001.14%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 120,000$3,240,0001.04%
TANG CAPITAL MANAGEMENT LLC 287,500$7,763,0000.95%
View complete list of REVANCE THERAPEUTICS INC shareholders